Drug distributor Cardinal sees sales boost from weight-loss drugs in 2024, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

The company added the trend would not add to its profit. It raised its 2024 profit forecast slightly to a range of $6.50 to $6.75 per share, from $6.45 to $6.70 it had forecast previously., The company added the trend would not add to its profit. It raised its 2024 profit forecast slightly to a range of $6.50 to $6.75 per share, from $6.45 to $6.70 it had forecast previously., , Read More

Leave a Reply

Your email address will not be published.